Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (3): 448-452    DOI: 10.12891/ceog3544.2017
Original Research Previous articles | Next articles
Effect of maternal pregnancy-induced hypertension on neonatal immunity
Na Lei1, *(), Zhaohua Tian1
1 Department of Gynaecology and Obstetrics, People's Hospital of Zhengzhou, Zhengzhou City, China
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  Objective: To explore the effect of pregnancy-induced hypertension (PIH) on immune system of neonate. Materials and Methods: Sixty neonates whose mothers suffered from PIH were selected and divided into preeclampsia group (n=28) and gestational hypertension (GH) group (n=32) according to severity of mother’s condition. Thirty neonates having healthy mothers were enrolled as control group. The base clinical characteristics of neonates were collected and umbilical vein blood was drawn to detect the distribution of T lymphocyte antigen, immune globulin, and complement level. Results: The gestational week, birth weight, head circumference, and oneminute Apgar score of both PIH groups were lower than those of control group, and preeclampsia group was lower than GH group (p < 0.05). There was significant difference between preeclampsia group and control group in blood routine and blood glucose levels. Concerning blood glucose levels, both PIH groups were lower than control group, and preeclampsia group was lower than GH group (p < 0.05). Content of IgG and complement C4 of GH group was lower than those of control group; IgG level of preeclampsia group was also lower than GH group (p < 0.05). Conclusions: PIH of pregnant mother affects the immunity of neonate, and more severe PIH will more negatively affect immunity of neonate.
Key words:  Pregnancy-induced hypertension      preeclampsia      gestational hypertension (GH)      immunity      neonate     
Published:  10 June 2017     
*Corresponding Author(s):  NA LEI     E-mail:  leina37@126.com

Cite this article: 

Na Lei, Zhaohua Tian. Effect of maternal pregnancy-induced hypertension on neonatal immunity. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 448-452.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3544.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I3/448

[1] Luca Roncati, Greta Gianotti, Elisa Ambrogi, Giovanna Attolini. COVID-19 in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 778-780.
[2] Silvia Amodeo, Giulia Bonavina, Anna Seidenari, Paolo Ivo Cavoretto, Antonio Farina. Real-world implementation and adaptation to local settings of first trimester preeclampsia screening in Italy: a systematic review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 812-819.
[3] Shingo Tanaka, Maki Goto, Saya Watanabe, Sachino Kira, Sotaro Hayashi, Shigeki Fujimoto, Miho Oda, Lifa Lee, Yoko To, Satoshi Nishiyama, Fuyuki Eguchi, Hiroshi Tsujioka. Posterior reversible encephalopathy syndrome with reversible cerebral vasoconstriction syndrome in a normal primigravida woman at the 35-week gestational stage: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 982-986.
[4] Lejla Kamerić, Anis Cerovac, Mirzeta Rizvanović, Alen Kamerić, Mahira Jahić, Dubravko Habek. Frequency of cesarean section in pregnant women with risk factors for preeclampsia: prospective cohort study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 561-566.
[5] Elisa Casella, Carla Ettore, Ferdinando Antonio Gulino, Elisa Pappalardo, Filippo Rapisarda, Stella Capriglione, Giuseppe Ettore. Two successful pregnancies after a simultaneous kidney and pancreas transplantation for type 1 diabetes mellitus-complicated nephropathy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 697-699.
[6] Yi Zhou, Ran Wang, Shi-Xian Chen, Li-Sheng Wu, Jun-Qing Zhu. Matrix metalloproteinase 9 gene promoter region -1562 C/T single nucleotide polymorphism increases the susceptibility to hypertensive disorders of pregnancy: a meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 245-252.
[7] Jing Wang, Min Zhou, Li Zhang, Long-Xin Zhang. Effective doses 50% and 95% of subarachnoid injection of sufentanil with ropivacaine in lumbar anesthesia for cesarean section in severe preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 105-109.
[8] R. Mihăilă. Coagulation challenges in pregnancy: from thrombophilia involvement and management to the utility of thrombin generation monitoring[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 814-820.
[9] Y.X. Wang, M. Zhong, H. Yi, H.F. He. Detection of group B streptococcus colonization in cervical and lower vaginal secretions of pregnant women[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 669-674.
[10] H.M. Kim, Y.S. Choo, W.J. Seong. Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 511-515.
[11] H. Yolli, M.E. Demir, R. Yildizhan. Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 519-523.
[12] A. E. Kholeif, M. Y. Khamis, S. Eltabakh, R. S. Swilam, A. Elhabashy, R. EISherif. Prediction of severity of preeclampsia in Egyptian patients: role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and C-reactive protein[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 183-188.
[13] W.X. Chen, L.Y. Tang. Relationship between subclinical hypothyroidism during pregnancy and hypertensive disorder complicating pregnancy and its poor prognosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 111-116.
[14] J. Yoon Park, S.W. Lee, K.J. Oh, J.-S. Hong. High mean blood pressure during the first trimester is predictive of future preeclampsia development in healthy pregnant women: a cohort study in Korea[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 770-775.
[15] Y. E. Purut, E. E. Buyukbayrak, F. Ercan, A. Orcun, M. Menke, A. Y. Karageyim Karsidag. Do first trimester maternal serum follistatin like 3 levels predict preeclampsia and/or related adverse pregnancy outcomes?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 195-200.
No Suggested Reading articles found!